Kopfgrafik

SHOP: Cell lysates

back Back to List

Cell lysate from PMA+pervanadate-treated HepG2 cells

Order No. Size sufficient for Price
0817/HepG2/PMA+VH 20 mini-gel lanes  92,00  €
Order No.: 0817/HepG2/PMA+VH
Description:
Specificity:
Size sufficient for: 20 mini-gel lanes 
Formulation: lyophilized
Applications: WB
Price: 92,00 €
0817/HepG2/PMA+VH

Related Products:

Order No. Cell lysate from Tissue Type
0811/HepG2/Co HepG2 cells, untreated hepatocellular carcinoma (human)
0812/HepG2/VH HepG2 cells, pervanadate-treated hepatocellular carcinoma (human)
0813/HepG2/EGF HepG2 cells, EGF-treated hepatocellular carcinoma (human)
0814/HepG2/Forskolin HepG2 cells, Forskolin-treated hepatocellular carcinoma (human)
0815/HepG2/IL-4 HepG2 cells, IL-4-treated hepatocellular carcinoma (human)
0816/HepG2shc/p66-IP shc/p66preciptated from EGF-treated HepG2 cells hepatocellular carcinoma (human)
0801/SW480/Co 0801/SW480/Co Cell lysate from untreated SW480 cells, colorectal adenocarcinoma (human)
0802/SW480/VH 0802/SW480/VH Cell lysate from pervanadate-treated SW480 cells, colorectal adenocarcinoma (human)
0803/SW480/LiCl 0803/SW480/LiCI Cell lysate from LiCl-treated SW480 cells, colorectal adenocarcinoma (human)
0811/HepG2/Co 0811/HepG2/Co Cell lysate from untreated HepG2 cells, hepatocellular carcinoma (human)
0812/HepG2/VH 0812/HepG2/VH Cell lysate from pervanadate-treated HepG2 cells, hepatocellular carcinoma (human)
0813/HepG2/EGF 0813/HepG2/EGF Cell lysate from EGF-treated HepG2 cells, hepatocellular carcinoma (human)
0814/HepG2/Forskolin 0814/HepG2/Forskolin Cell lysate from Forskolin-treated HepG2 cells, hepatocellular carcinoma (human)
0815/HepG2/IL-4 0815/HepG2/IL-4 Cell lysate from IL-4-treated HepG2 cells, hepatocellular carcinoma (human)
0816/HepG2shc/p66-IP 0816/HepG2shc/p66-IP precipitated from EGF-treated HepG2 cells
0821/HeLa/Co 0821/HeLa/Co Cell lysate from untreated HeLa cells, epitheloid cervical carcinoma (human)
0822/HeLa/VH 0822/HeLa/VH Cell lysate from pervanadate-treated HeLa cells, epitheloid cervical carcinoma (human)
0831/A431/Co 0831/A431/Co Cell lysate from untreated A431 cells, epidermoid carcinoma (human)
0832/A431/VH 0832/A431/VH Cell lysate from pervanadate-treated A431 cells, epidermoid carcinoma (human)
0833/A431/PMA+VH 0833/A431/PMA+VH Cell lysate from PMA+pervanadate-treated A431 cells, epidermoid carcinoma (human)
0834/A431/Sorbit 0834/A431/Sorbit Cell lysate from Sorbit-treated A431 cells, epidermoid carcinoma (human)
0841/Jurkat/Co 0841/Jurkat/Co Cell lysate from untreated Jurkat cells, T-cell leukemia (human)
0842/Jurkat/VH 0842/Jurkat/VH Cell lysate from pervanadate-treated Jurkat cells, T-cell leukemia (human)
0851/THP-1/Co 0851/THP-1/Co Cell lysate from untreated THP-1 cells, acute monocytic leukemia (human)
0852/THP-1/VH 0852/THP-1/VH Cell lysate from pervanadate-treated THP-1 cell, acute monocytic leukemia (human)
0861/3T3/Co 0861/3T3/Co Cell lysate from untreated NIH 3T3 cells, embryonic fibroblast (mouse)
0862/3T3/VH 0862/3T3/VH Cell lysate from pervanadate-treated NIH 3T3 cells
0871/293/Co 0871/293/Co Cell lysate from untreated HEK293 cells, human epithelial cell line (kidney)
0872/293/VH 0872/293/VH Cell lysate from pervanadate-treated HEK293 cells, human epithelial cell line (kidney)
0873/293/Insulin 0873/293/Insulin Cell lysate from Insulin-treated HEK293 cells, human epithelial cell line (kidney)
0874/293/IGF1 0874/293/IGF1 Cell lysate from IGF1-treated HEK293 cells, human epithelial cell line (kidney)
0881/MCF-7/Co 0881/MCF-7/Co Cell lysate from untreated MCF-7 cells, breast adenocarcinoma (human)
0882/MCF-7/VH 0882/MCF-7/VH Cell lysate from pervanadate-treated MCF-7 cells, breast adenocarcinoma (human)
0891/Bend3/Co 0891/Bend3/Co Cell lysate from untreated Bend3 cells, brain endothelioma (mouse)
0892/Bend3/VH 0892/Bend3/VH Cell lysate from pervanadate-treated Bend3 cells, brain endothelioma (mouse)
0901/PSERCO 0901/PSERCO pSer/p Thr molecular weight marker, phosphoproteins from rabbit muscle
0911/liquid/Neuro2A/Co 0911/liquid/Neuro2A/Co Cell lysate from untreated Neuro2A, brain endothelioma (mouse); Formulation: liquid
0911/Neuro2A/Co 0911/Neuro2A/Co, Cell lysate from untreated Neuro2A cells, brain endothelioma (mouse)
0912/Neuro2A/VH 0912/Neuro2A/VH Cell lysate from pervanadate-treated Neuro2A cells, brain endothelioma (mouse)
0921/K46/Co 0921/K46/Co Cell lysate from untreated K46 cells, B-cell lymphoma (mouse)
0922/K46/VH 0922/K46/VH Cell lysate from pervanadate-treated K46 cells, B-cell lymphoma (mouse)
0923/K46/PMA 0923/K46/PMA Cell lysate from PMA-treated K46 cells, B-cell lymphoma (mouse)
0931/PC12/Co 0931/PC12/Co Cell lysate from untreated PC12 cells, adrenal pheochromocytoma (rat)
0932/PC12/Sorbit 0932/PC12/Sorbit Cell lysate from Sorbit-treated PC12 cells, adrenal pheochromocytoma (rat)
0933/PC12/Forskolin 0933/PC12/Forskolin Cell lysate from Forskolin-treated PC12 cells, adrenal pheochromocytoma (rat)
0941/MDCK/Co 0941/MDCK/Co Cell lysate from untreated MDCK cells, kidney carcinoma (dog)
0942/MDCK/VH 0942/MDCK/VH Cell lysate from pervanadate-treated MDCK cells, kidney carcinoma (dog)
0961/SW620/Co 0961/SW620/Co Cell lysate from untreated SW620 cells, colorectal adenocarcinoma (human)
0962/SW620/VH 0962/SW620/VH Cell lysate from pervanadate-treated SW620 cells, colorectal adenocarcinoma (human)
0971/HT29/Co 0971/HT29/Co Cell lysate from untreated HT 29 cells, colorectal adenocarcinoma (human)
0981/10T1/2mCad 0981/10T1/2mCad Cell lysate from 10T1/2 cells transfected with mCadherin, embryonic fibroblast (mouse)
0991/SKOV3/Co 0991/SKOV3/Co Cell lysate from untreated SKOV-3 cells, ovary adenocarcinoma (human)
0992/SKOV3/VH 0992/SKOV3/VH Cell lysate from pervanadate-treated SKOV-3 cells, ovary adenocarcinoma (human)
0993/SKOV3/EGF 0993/SKOV3/EGF Cell lysate from EGF-treated SKOV-3 cells, ovary adenocarcinoma (human)
0994/SKOV3/PMA+VH 0994/SKOV3/PMA+VH Cell lysate from PMA+pervanadate-treated SKOV-3 cells, ovary adenocarcinoma (human)
0995/SKOV3/Fors.+IBMX 0995/SKOV3/Fors.+IBMX Cell lysate from Forskolin+IBMX-treated SKOV-3 cells, ovary adenocarcinoma (human)
1001/SH-SY5Y/Co 1001/SH-SY5Y/Co Cell lysate from untreated SH-SY5Y cells, brain neuroblastoma (human)
1002/SH-SY5Y/VH 1002/SH-SY5Y/VH Cell lysate from pervanadate-treated SH-SY5Y cells, brain neuroblastoma (human)
1001/SH-SY5Y/Co 1001/SH-SY5Y/Co Cell lysate from untreated SH-SY5Y cells, brain neuroblastoma (human)
1002/SH-SY5Y/VH 1002/SH-SY5Y/VH Cell lysate from pervanadate-treated SH-SY5Y cells, brain neuroblastoma (human)
1011/T47D/Co 1011/T47D/Co Cell lysate from untreated T47D cells, ductal carcinoma (human)
1012/T47D/VH 1012/T47D/VH Cell lysate from pervanadate-treated T47D cells, ductal carcinoma (human)
1021/MDA468/Co 1021/MDA468/Co Cell lysate from untreated MDA-MB-468 cells, breast adenocarcinoma (human)
1022/MDA468/VH 1022/MDA468/VH Cell lysate from pervanadate-treated MDA-MB-468 cells, breast adenocarcinoma (human)
1023/MDA468/EGF 1023/MDA468/EGF Cell lysate from EGF-treated MDA-MB-468 cells, breast adenocarcinoma (human)
1031/MDA231/Co 1031/MDA231/Co Cell lysate from untreated MDA-MB-231 cells, breast adenocarcinoma (human)
1032/MDA231/VH 1032/MDA231/VH Cell lysate from pervanadate-treated MDA-MB-231 cells, breast adenocarcinoma (human)
1033/MDA231/EGF 1033/MDA231/EGF Cell lysate from EGF-treated MDA-MB-231 cells, breast adenocarcinoma (human)
1041/PC3/LC3I 1041/PC3/LC3I, 1041, PC3, LC3 I, cell fraction containing LC3 I was prepared from semiconfluent PC3 cells with LC3 I buffer
1042/PC3/LC3II 1042/PC3/LC3II, 1042, PC3, LC3 II, cell fraction containing LC3 II was prepared from semiconfluent PC3 cells with LC3 I buffer

Further Information

Datasheet
0817/HepG2/PMA+VH